3/24
09:50 am
pyxs
Pyxis Oncology (PYXS) had its price target lowered by Stifel Nicolaus from $9.00 to $8.00. They now have a "buy" rating on the stock.
Medium
Report
Pyxis Oncology (PYXS) had its price target lowered by Stifel Nicolaus from $9.00 to $8.00. They now have a "buy" rating on the stock.
3/24
08:03 am
pyxs
Pyxis Oncology (PYXS) had its "buy" rating reaffirmed by HC Wainwright. They now have a $7.00 price target on the stock.
Medium
Report
Pyxis Oncology (PYXS) had its "buy" rating reaffirmed by HC Wainwright. They now have a $7.00 price target on the stock.
3/23
07:19 am
pyxs
Pyxis Oncology GAAP EPS of -$1.28 misses by $0.93, revenue of $13.9M [Seeking Alpha]
Medium
Report
Pyxis Oncology GAAP EPS of -$1.28 misses by $0.93, revenue of $13.9M [Seeking Alpha]
3/23
07:09 am
pyxs
Pyxis Oncology Provides Business Update and Reports Fourth Quarter and Full Year 2025 Financial Results [Yahoo! Finance]
Low
Report
Pyxis Oncology Provides Business Update and Reports Fourth Quarter and Full Year 2025 Financial Results [Yahoo! Finance]
3/23
07:00 am
pyxs
Pyxis Oncology Provides Business Update and Reports Fourth Quarter and Full Year 2025 Financial Results
Low
Report
Pyxis Oncology Provides Business Update and Reports Fourth Quarter and Full Year 2025 Financial Results
3/15
01:05 am
pyxs
High
Report
3/7
02:59 am
pyxs
Medium
Report
2/3
07:01 am
pyxs
Pyxis Oncology Announces Interim CEO Appointment and Leadership Transition to Support Strategic Focus and Program Continuity [Yahoo! Finance]
Low
Report
Pyxis Oncology Announces Interim CEO Appointment and Leadership Transition to Support Strategic Focus and Program Continuity [Yahoo! Finance]
2/3
06:45 am
pyxs
Pyxis Oncology Announces Interim CEO Appointment and Leadership Transition to Support Strategic Focus and Program Continuity
Low
Report
Pyxis Oncology Announces Interim CEO Appointment and Leadership Transition to Support Strategic Focus and Program Continuity
1/25
03:05 am
pyxs
Pyxis Oncology (NASDAQ:PYXS) was downgraded by analysts at
Wall Street Z
Neutral
Report
Pyxis Oncology (NASDAQ:PYXS) was downgraded by analysts at
Wall Street Z
1/17
01:11 am
pyxs
Medium
Report